Immunogenicity of intranasal vaccine based on SARS-CoV-2 spike protein during primary and booster immunizations in mice

Supporters

Support the authors with ResearchCoin

Tip RSC

Journal

Human Vaccines & Immunotherapeutics

Topics

Physics

Epidemiology

Medicine

Immunology

Microbiology

Show all topics

DOI

10.1080/21645515.2024.2364519

License

CC-BY-NC

Other Formats

PDF